Drawing for HEALIVA

USPTO serial 79324650

HEALIVA

Reviewed by CopyMark Law Group

Reg. 7014607Status 700Registered
Filing date
Status date
Registration date
Apr 4, 2023
Examiner
SMITH, CYNTHIA RINALDI
Law office
PUBLICATION AND ISSUE SECTION

What this means

Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.

Status 700: Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six.

Need help with HEALIVA?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Barry I. Friedman

Barry I. Friedman Metz Lewis Brodman Must O'Keefe535 Smithfield Street - Suite 800Pittsburgh, PA 15222UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
005Medicines, namely, enzymes for medical use; pharmaceutical preparations for the treatment of damaged skin and tissue; cells for medical use; living cells for medical use; pharmaceutical preparations containing stem cells for the treatment of damaged skin and tissue; stem cells for medical use; stem cells for veterinary use; implants comprising living tissue; surgical implants comprised of living tissues; surgical implants comprised of living tissue grown from stem cells; bone void fillers comprised of living tissues; pharmaceutical preparations for tissue regeneration; enzymes for veterinary useACTIVE—
042Biomedical engineering, namely, tissue engineering; analysis of human tissues being medical research; scientific research relating to the isolation and cultivation of human tissues and cells; genetic engineering services; scientific research in the field of genetics and genetic engineering; advisory services relating to gene therapy research; research in the field of gene therapyACTIVE—
044Stem cell therapy services; medical analysis of human tissues for medical treatment of persons; stem cell storage; medical services relating to the removal, treatment and processing of stem cells; medical services relating to the removal, treatment and processing of human cells; medical and health care services relating to DNA, genetics and genetic testing; genetic testing for medical use; genetic counseling; regenerative medicine services; medical services in the field of treatment of chronic conditions; medical services in the field of wound healingACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Aug 14, 2023FINOFINAL DECISION TRANSACTION PROCESSED BY IB—
Jul 21, 2023FICSFINAL DISPOSITION NOTICE SENT TO IB—
Jul 21, 2023FIMPFINAL DISPOSITION PROCESSED—
Jul 4, 2023FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB—
Apr 4, 2023NRCCNOTICE OF REGISTRATION CONFIRMATION EMAILED—
Apr 4, 2023R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Jan 24, 2023GPNXNOTIFICATION PROCESSED BY IB—
Jan 17, 2023NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Jan 17, 2023PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Jan 4, 2023OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB—
Jan 4, 2023OP2RNOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB—
Dec 28, 2022NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Dec 14, 2022CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Dec 14, 2022XAECEXAMINER'S AMENDMENT ENTERED—
Dec 14, 2022GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Dec 14, 2022GNEAEXAMINERS AMENDMENT E-MAILED—
Dec 14, 2022CNEAEXAMINERS AMENDMENT -WRITTEN—
Nov 18, 2022TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Nov 17, 2022CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Nov 17, 2022TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Nov 17, 2022CHANAPPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED—
Nov 17, 2022TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Nov 17, 2022ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Nov 17, 2022REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Nov 17, 2022COARTEAS CHANGE OF OWNER ADDRESS RECEIVED—
Aug 9, 2022RFNPREFUSAL PROCESSED BY IB—
Jul 20, 2022RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
Jul 19, 2022RFRRREFUSAL PROCESSED BY MPU—
Jun 25, 2022RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Jun 24, 2022CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jun 22, 2022DOCKASSIGNED TO EXAMINER—
Nov 9, 2021MAFRAPPLICATION FILING RECEIPT MAILED—
Nov 5, 2021NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Nov 4, 2021REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance